Employees: 11-50
Total raised: $17.7M
Founded date: 2004
Funding Rounds 2
Date | Series | Amount | Investors |
18.07.2022 | - | $15.9M | - |
26.04.2016 | Series A | $1.8M | - |
Mentions in press and media 14
Date | Title | Description | Source |
20.03.2024 | Biofactura, Inc. Expands presence at Riverside Tech Park in ... | BioFactura Biotechnology company consolidates operations in business community and expects to employ... | prweb.com/... |
11.09.2023 | BioFactura, Inc. publishes Phase 1 data on its Ustekinumab b... | BioFactura BioFactura, Inc. announced the publication of the phase 1 study for BFI-751, a biosimilar... | prweb.com/... |
10.07.2023 | BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A ... | BioFactura Jeffrey N Hausfeld, MD, MBA., Chairman and Chief Medical Officer of BioFactura, stated, &... | prweb.com/... |
14.10.2022 | BioFactura’s BFI-751, a Biosimilar Ustekinumab, Demonstrates... | "Meeting the primary endpoint of clinical bioequivalence in this trial, along with our bioanaly... | prweb.com/... |
13.10.2022 | BioFactura’s Biosimilar Ustekinumab, Demonstrates Pharmacoki... | • Phase 1 clinical study demonstrated PK bioequivalence and comparable safety and immunogenicity pro... | einpresswi... |
18.07.2022 | BioFactura Announces Activation of a $15.9M Contract Option ... | BioFactura today announced its second contract option activation of $15.9 million from the Biomedica... | einpresswi... |
15.07.2022 | BioFactura Announces Activation of a $15.9M Contract Option ... | “This funding confirms BARDA’s continued commitment to support development of this important product... | prweb.com/... |
19.02.2021 | BioFactura Funded $13 Million Contract Option for its Smallp... | Dr. Darryl Sampey, President and CEO of BioFactura, stated, “Funding of our first option confirms th... | prweb.com/... |
15.03.2017 | Notes on a pair of recent Maryland moves | The area around Columbia and Annapolis Junction along Route 32 is home to lots of tech talent, and i... | technical.... |
27.04.2016 | BioFactura Closes $1.8M Series A Funding | FREDERICK, MD, Biopharmaceutical research and manufacturing company, announced today the closing o... | vcnewsdail... |
Show more